Maquet Cardiopulmonary GmbHJune 24, 2022

FDA 483 - Maquet Cardiopulmonary GmbH - June 24, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Maquet Cardiopulmonary GmbH

Record Details

An FDA inspection of Maquet Cardiopulmonary GmbH in Hechingen, Germany, revealed significant deficiencies across multiple quality system areas. The firm failed to adequately establish and implement procedures for corrective and preventive actions, design validation, risk analysis, design review, and process validation. These issues are particularly severe as the firm was previously issued a 483 in 2013 for similar deficiencies, leading to a Consent Decree in 2015.

Company: Maquet Cardiopulmonary GmbH
Inspection Date: June 24, 2022
Product Type: Device
Office: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Person: Joshua J. Silvestri

Open in Dashboard

ID · 72c6f95d-aeab-43b9-afab-c2e7a15ecb9c